Literature DB >> 2438441

Effect of the substance P antagonist spantide on adrenal sympathetic nerve activity in rats.

H Togashi, M Yoshioka, M Minami, K Shimamura, H Saito, C Kitada, M Fujino.   

Abstract

In order to elucidate the role of substance P in adrenal nerve activity, the effects of substance P antagonists on tonic activity of the adrenal sympathetic nerve, the response to exogenous substance P and cutaneo-adrenal nerve reflex were investigated in anesthetized rats. Substance P or its antagonist [(Arg1, D-Trp7,9, Leu11)-substance P: spantide] was injected into the subarachnoid space via polyethylene tubing. Intrathecal administration of spantide (0.1-10 micrograms) produced a slight and transient increase in tonic activity of the adrenal nerve. Thereafter, a marked and prolonged decrease in adrenal nerve activity was observed, along with a decrease in arterial blood pressure. Intrathecally administered substance P (0.1-10 micrograms) produced a marked increase in tonic activity of the adrenal nerve in a dose-related manner. This substance P-induced increase in adrenal nerve activity was significantly antagonized by pretreatment with spantide. It was also found that spantide depressed the reflex response in adrenal nerve activity evoked by noxious mechanical pinching of the skin. These findings suggest the possibility that on the spinal level, substance P has an important role in the maintenance of tonic activity of the adrenal nerve and the transmission of nociceptive information to the adrenal nerve in rats.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438441     DOI: 10.1254/jjp.43.253

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Pharmacological profile of a tachykinin antagonist, spantide, as examined on rat spinal motoneurones.

Authors:  M Yanagisawa; M Otsuka
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

2.  Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.

Authors:  P A Johnston; L A Chahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.